A detailed history of Raymond James & Associates transactions in Danaher Corp stock. As of the latest transaction made, Raymond James & Associates holds 1,309,378 shares of DHR stock, worth $307 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
1,309,378
Previous 1,339,544 2.25%
Holding current value
$307 Million
Previous $335 Million 8.76%
% of portfolio
0.23%
Previous 0.22%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$239.25 - $280.76 $7.22 Million - $8.47 Million
-30,166 Reduced 2.25%
1,309,378 $364 Million
Q2 2024

Jul 19, 2024

SELL
$235.51 - $267.98 $875,155 - $995,813
-3,716 Reduced 0.28%
1,339,544 $335 Million
Q1 2024

Apr 22, 2024

BUY
$224.58 - $256.19 $16.6 Million - $18.9 Million
73,960 Added 5.83%
1,343,260 $335 Million
Q4 2023

Jan 16, 2024

BUY
$185.1 - $233.13 $7 Million - $8.82 Million
37,834 Added 3.07%
1,269,300 $294 Million
Q3 2023

Oct 24, 2023

BUY
$233.08 - $265.59 $219,561 - $250,185
942 Added 0.08%
1,231,466 $306 Million
Q2 2023

Jul 25, 2023

BUY
$224.99 - $256.14 $560,000 - $637,532
2,489 Added 0.2%
1,230,524 $295 Million
Q1 2023

Apr 14, 2023

BUY
$239.75 - $277.0 $11.2 Million - $12.9 Million
46,642 Added 3.95%
1,228,035 $310 Million
Q4 2022

Feb 08, 2023

BUY
$241.42 - $282.29 $43.9 Million - $51.3 Million
181,777 Added 18.18%
1,181,393 $314 Million
Q3 2022

Oct 25, 2022

BUY
$247.06 - $1507.4 $4.61 Million - $28.2 Million
18,678 Added 1.9%
999,616 $258 Million
Q2 2022

Aug 12, 2022

BUY
$237.11 - $299.66 $8.51 Million - $10.8 Million
35,901 Added 3.8%
980,938 $249 Million
Q1 2022

May 11, 2022

BUY
$257.27 - $315.76 $1.52 Million - $1.86 Million
5,895 Added 0.63%
945,037 $277 Million
Q4 2021

Feb 08, 2022

BUY
$292.08 - $329.01 $1.47 Million - $1.66 Million
5,042 Added 0.54%
939,142 $309 Million
Q3 2021

Nov 02, 2021

BUY
$272.21 - $332.43 $7.13 Million - $8.71 Million
26,192 Added 2.88%
934,100 $284 Million
Q2 2021

Aug 11, 2021

BUY
$225.08 - $271.69 $17.5 Million - $21.1 Million
77,709 Added 9.36%
907,908 $244 Million
Q1 2021

May 14, 2021

BUY
$212.38 - $245.9 $10.4 Million - $12 Million
48,825 Added 6.25%
830,199 $187 Million
Q4 2020

Feb 12, 2021

BUY
$212.5 - $245.46 $4.93 Million - $5.69 Million
23,201 Added 3.06%
781,374 $174 Million
Q3 2020

Nov 04, 2020

BUY
$177.16 - $215.33 $2.35 Million - $2.85 Million
13,242 Added 1.78%
758,173 $163 Million
Q2 2020

Jul 28, 2020

BUY
$128.7 - $176.83 $5.12 Million - $7.04 Million
39,821 Added 5.65%
744,931 $132 Million
Q1 2020

Apr 21, 2020

BUY
$121.39 - $169.05 $9.67 Million - $13.5 Million
79,666 Added 12.74%
705,110 $97.6 Million
Q4 2019

Feb 12, 2020

BUY
$133.47 - $153.48 $5.21 Million - $5.99 Million
39,024 Added 6.65%
625,444 $96 Million
Q3 2019

Nov 07, 2019

SELL
$135.4 - $146.47 $4 Million - $4.33 Million
-29,540 Reduced 4.8%
586,420 $84.7 Million
Q2 2019

Aug 06, 2019

BUY
$124.88 - $143.73 $7.88 Million - $9.07 Million
63,071 Added 11.41%
615,960 $88 Million
Q1 2019

May 06, 2019

BUY
$97.62 - $132.29 $1.06 Million - $1.44 Million
10,877 Added 2.01%
552,889 $73 Million
Q4 2018

Feb 11, 2019

BUY
$94.85 - $109.54 $1.05 Million - $1.22 Million
11,104 Added 2.09%
542,012 $55.9 Million
Q3 2018

Nov 14, 2018

BUY
$98.13 - $108.9 $5.83 Million - $6.47 Million
59,403 Added 12.6%
530,908 $57.7 Million
Q2 2018

Aug 14, 2018

BUY
$96.1 - $103.24 $660,014 - $709,052
6,868 Added 1.48%
471,505 $46.5 Million
Q1 2018

May 14, 2018

BUY
$92.16 - $103.8 $3.04 Million - $3.43 Million
33,016 Added 7.65%
464,637 $45.5 Million
Q4 2017

Feb 14, 2018

BUY
$85.26 - $94.62 $3.52 Million - $3.91 Million
41,338 Added 10.59%
431,621 $40.1 Million
Q3 2017

Nov 13, 2017

SELL
$79.29 - $88.45 $1.39 Million - $1.55 Million
-17,572 Reduced 4.31%
390,283 $33.5 Million
Q2 2017

Aug 14, 2017

BUY
N/A
407,855
407,855 $34.4 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $171B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.